ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Novelix Pharmaceuticals approved a Rs. 6.84 Crore preferential allotment of 12,00,000 equity shares. The capital raise targets non-promoter investors at Rs. 57 per share.
Novelix Pharmaceuticals allotted new equity shares to its promoter group via a preferential offer. This issuance increases promoter stake through a formal regulatory allotment process.
Novelix Pharmaceuticals reported zero deviation in the utilization of ₹16.25 Crore raised through preferential issues. The Audit Committee reviewed and confirmed the funds were used as intended.